Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation
- PMID: 2138932
- PMCID: PMC11037997
- DOI: 10.1007/BF01742369
Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation
Abstract
The kinetics of interleukin-2 receptor (IL-2R) expression and the [3H]dT incorporation of blood lymphocytes after the first and the second stimulation with allogeneic leukocytes (primary and secondary MLC) or with the autologous tumor cells (primary and secondary MLTC) were compared. The expression of IL-2R paralleled the induction of DNA synthesis. The proportion of IL-2R+ cells of the unprimed donors peaked earlier in the secondary MLC as compared to the primary MLC (on days 3 and 5 respectively). In MLC of alloimmunized healthy individuals and in the MLTC of cancer patients the highest proportions of IL-2R+ cells were detected between days 2 and 3 after both the first and second stimulations. Thus the first in vitro stimulation in the MLTC showed similar kinetics to those of the secondary MLC of unprimed individuals and to the primary MLC response of the allo-immunized individuals. The findings in the MLTC substantiate the hypothesis that cancer patients can be sensitized to their own tumors. The kinetics of the appearance of the IL-2R together with the characteristics of the IL-2-propagated cultures provide useful information for the strategy of expansion of auto-tumor reactive lymphocyte populations.
Similar articles
-
Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.Cancer Immunol Immunother. 1983;15(3):227-36. doi: 10.1007/BF00199170. Cancer Immunol Immunother. 1983. PMID: 6225511 Free PMC article.
-
Lymphocyte interleukin 2 production and responsiveness are altered in patients with primary myelodysplastic syndrome.Blood. 1987 Aug;70(2):494-500. Blood. 1987. PMID: 2955819
-
Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2.Int J Cancer. 1982 Jan 15;29(1):33-9. doi: 10.1002/ijc.2910290107. Int J Cancer. 1982. PMID: 6460704
-
Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.J Exp Med. 1982 Jan 1;155(1):83-95. doi: 10.1084/jem.155.1.83. J Exp Med. 1982. PMID: 6459402 Free PMC article.
-
Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity.Cancer Immunol Immunother. 1989;29(2):125-32. doi: 10.1007/BF00199287. Cancer Immunol Immunother. 1989. PMID: 2470505 Free PMC article.
References
-
- Ashwell JD, Robb RJ, Malek TR. Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activation. J Immunol. 1986;137:2572. - PubMed
-
- Leonard WJ, Depper JM, Uchiyama T, Smith KA, Waldmann TA, Greene WC. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature. 1982;300:267. - PubMed
-
- Lipkowitz S, Greene WC, Rubin AL, Novogrodsky A, Stenzel KH. Expression of receptors for interleukin 2: role in the commitment of T lymphocytes to proliferate. J Immunol. 1984;132:31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources